This page contains exclusive content for the member of the following sections: TTS, IXA, ITA. Log in to view.
Industry Symposium Sponsored by TEVA Pharmaceutical: The immunosuppressive therapy after intestinal transplantation - where are we?
23.332 - Case study 2: ‘Vascular graft injury due to antibody-mediated rejection 10 years after intestinal transplantation’
Presenter: Undine A., Gerlach, , Germany Authors:
Important
Disclaimer
By viewing the material on this site you understand and
accept that:
The opinions and statements expressed on this site reflect the
views of the author or authors and do not necessarily reflect those of
The Transplantation Society and/or its Sections.
The hosting of material on The Transplantation Society site does
not signify endorsement of this material by The Transplantation Society
and/or its Sections.
The material is solely for educational purposes for qualified
health care professionals.
The Transplantation Society and/or its Sections are not liable for
any decision made or action taken based on the information contained in
the material on this site.
The information cannot be used as a substitute for professional
care.
The information does not represent a standard of care.
No physician-patient relationship is being established.